3D Bioprinting Market Overview
The 3D bioprinting market was valued USD 1.6 billion in 2021 and expected to reach USD 5.1 Billion by 2030 at a CAGR of 15.4% during the forecast period 2022-2030, says Market Research Future.
The technology related to 3D bioprinting has been witnessing a huge rate of adoption in the recent past and mainly in the healthcare industry. Bioprinting has witnessed a huge momentum in the form of a promising technology for its relationship with the ability of tissue fabrication for artificial tissues and organs. 3D Bioprinting refers to additive manufacturing that utilizes 3D printing to manufacture biomedical parts that maximally imitate natural tissue characteristics. Generally, 3D Bioprinting applies the layer-by-layer method to combine materials called bioinks, to form tissue-like structures that are later utilized in medical and tissue engineering fields. The process of 3D Bioprinting usually comprises three stages: pre-bioprinting, bioprinting, and post-bioprinting. 3D Bioprinting is generally applied for developing organ and tissue constructs that can be utilized for the R&D of drugs, scaffolds, and the development of medical implants. In addition, 3D Bioprinting has started to incorporate the printing of scaffolds that can be utilized to regenerate joints and ligaments.
The upsurge in the usage of 3D printing in cosmetic surgeries and inventions in 3D bioprinting is expected to further bolster the 3D Bioprinting Market growth during the forecast period. The upsurge in public and private funding to assist bioprinting research activities has similarly added fuel to the market growth. Also, the increasing support for bioprinting research activities is on the roll that exhibits good growth for 3D bioprinting during the coming years.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/869
The Global 3D Bioprinting Market report provides an integrated evaluation of the market. The report provides a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a significant role in the market.
Market Segmentation
The Global 3D Bioprinting Market is segmented into the following types;
By Technology
- Magnetic Levitation
- Inkjet-based
- Syringe-based
- Laser-based
- Others
By Application
- Medical
- Tissue and organ generation
- Medical pills
- Prosthetics and implants
- Others
- Dental
- Biosensors
- Consumer/Personal Product Testing
- Bioinks
- Food and Animal Product
By Material
- Hydrogels
- Living cells
- Extracellular matrices
- Other biomaterials
By Component
- Bioprinters
- Bioinks
By End-use
- Pharmaceutical Companies
- Research & Academic Institutions
- Medical Device Manufacturers
- Contract Research Organization
Regional Analysis
The Global 3D Bioprinting Market is divided into five regions; North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
The Asia Pacific market is anticipated to hold the largest market share due to growing R & D activities, rearing demand for organ transplants, and an augmenting number of initiatives by market players for expanding their presence in the APAC.
The North American market attained a revenue share of 31.6% in 2021 and is projected to lead throughout the forecast period. The growing incorporation of IT in the healthcare industry is anticipated to stimulate the growth of the market over the forecast period.
3D Bioprinting market growth in Europe is estimated to grow at an accelerated pace during the forecast period.
Browse In-depth Market Research Report (110 Pages) on 3D Bioprinting: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
Key Players
The Global 3D Bioprinting Market’s prominent key players are REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), Poietis (France), EnvisionTEC GmbH (Germany), Cellink AB (Sweden) and Cyfuse Biomedical K.K. (Japan).
Browse Related Reports at:
3D Printing Medical Devices Market by Types (surgical guides and others), by Component (system and others), by Technology (3D printing and others), by Application (external wearable devices, implants and others), by End-users – Forecast till 2027
3D Printed Medical Implants Market Research Report: by Component Type (Materials, Services, System), Implantation Technology (Laser Beam Melting, Electronic Beam Melting, Droplet Deposition), Application (Dental, Orthopedic, Cranio-Maxillofacial)- Forecast till 2030
3D Printing Medical Device Software Market Information by Type (Integrated, Standalone), Function (Printing, Analysis, Planning, Design, Visualization, Navigation), Application (Medical Imaging, Dental, Surgery, Research, Physical Therapy, Aesthetic Medicine), End User (Medical, Device Companies, Dental Laboratories, Hospitals and Clinics, Research Institutes) and Region (Americas, Europe, Asia-Pacific, the Middle East & Africa)—Forecast till 2027
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com